Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cassiman

Showing results (71-80 of 201) with videos related to

Pageof 21
Sort By:
Expert Review of Molecular Diagnostics|February 15, 2014
Defining the phenotype and diagnostic considerations in adults with congenital disorders of N-linked glycosylationDavid F G J Wolthuis, Miriam C Janssen, David Cassiman, et al.
Journal of Inherited Metabolic Disease|March 12, 2017
NTCP deficiency and persistently raised bile salts: an adult caseFilip Van Herpe, Hans R Waterham, Christopher J Adams, et al.
Journal of Mother and Child|March 8, 2021
A Patient with neonatal cholestasisKristl G Claeys, Luc Breysem, Eric Legius, et al.
Acta Gastro-Enterologica Belgica|August 1, 2013
Treatment of non-alcoholic fatty liver disease: can we already face the epidemic?Jef Verbeek, David Cassiman, Matthias Lannoo, et al.
Microbial Cell (Graz, Austria)|March 31, 2017
Angiotensin II type 1 receptor blockers increase tolerance of cells to copper and cisplatinPieter Spincemaille, Gursimran Chandhok, Andree Zibert, et al.
JIMD Reports|June 22, 2015
Liver Fibrosis Associated with Iron Accumulation Due to Long-Term Heme-Arginate Treatment in Acute Intermittent Porphyria: A Case SeriesBarbara Willandt, Janneke G Langendonk, Katharina Biermann, et al.
Expert Review of Gastroenterology & Hepatology|July 26, 2011
Acute-on-chronic liver failure: current concepts on definition, pathogenesis, clinical manifestations and potential therapeutic interventionsWim Laleman, Len Verbeke, Philippe Meersseman, et al.
Orphanet Journal of Rare Diseases|August 26, 2022
Disease burden in patients with acute hepatic porphyria: experience from the phase 3 ENVISION studyBruce Wang, Paolo Ventura, Kei-Ichiro Takase, et al.
Orphanet Journal of Rare Diseases|March 21, 2021
D-galactose supplementation in individuals with PMM2-CDG: results of a multicenter, open label, prospective pilot clinical trialPeter Witters, Hans Andersson, Jaak Jaeken, et al.
The American Journal of Surgical Pathology|October 26, 2006
Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodulesLouis Libbrecht, Tamara Severi, David Cassiman, et al.
Pageof 21

Showing results (71-80 of 201) with videos related to

Sort By:
Pageof 21
Expert Review of Molecular Diagnostics|February 15, 2014
Defining the phenotype and diagnostic considerations in adults with congenital disorders of N-linked glycosylationDavid F G J Wolthuis, Miriam C Janssen, David Cassiman, et al.
Journal of Inherited Metabolic Disease|March 12, 2017
NTCP deficiency and persistently raised bile salts: an adult caseFilip Van Herpe, Hans R Waterham, Christopher J Adams, et al.
Journal of Mother and Child|March 8, 2021
A Patient with neonatal cholestasisKristl G Claeys, Luc Breysem, Eric Legius, et al.
Acta Gastro-Enterologica Belgica|August 1, 2013
Treatment of non-alcoholic fatty liver disease: can we already face the epidemic?Jef Verbeek, David Cassiman, Matthias Lannoo, et al.
Microbial Cell (Graz, Austria)|March 31, 2017
Angiotensin II type 1 receptor blockers increase tolerance of cells to copper and cisplatinPieter Spincemaille, Gursimran Chandhok, Andree Zibert, et al.
JIMD Reports|June 22, 2015
Liver Fibrosis Associated with Iron Accumulation Due to Long-Term Heme-Arginate Treatment in Acute Intermittent Porphyria: A Case SeriesBarbara Willandt, Janneke G Langendonk, Katharina Biermann, et al.
Expert Review of Gastroenterology & Hepatology|July 26, 2011
Acute-on-chronic liver failure: current concepts on definition, pathogenesis, clinical manifestations and potential therapeutic interventionsWim Laleman, Len Verbeke, Philippe Meersseman, et al.
Orphanet Journal of Rare Diseases|August 26, 2022
Disease burden in patients with acute hepatic porphyria: experience from the phase 3 ENVISION studyBruce Wang, Paolo Ventura, Kei-Ichiro Takase, et al.
Orphanet Journal of Rare Diseases|March 21, 2021
D-galactose supplementation in individuals with PMM2-CDG: results of a multicenter, open label, prospective pilot clinical trialPeter Witters, Hans Andersson, Jaak Jaeken, et al.
The American Journal of Surgical Pathology|October 26, 2006
Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodulesLouis Libbrecht, Tamara Severi, David Cassiman, et al.
Pageof 21